常茂生物(00954.HK)盈喜:預期2022年歸母淨利7000萬元至9000萬元
格隆匯3月16日丨常茂生物(00954.HK)公吿,集團於2021年度錄得歸屬於公司權益持有人的綜合淨利潤約人民幣5830萬元。集團就其常州生產廠房的若干生產線的拆除從政府收取的補償確認收益約人民幣1.265億元("拆遷收益")。拆遷已於2021年度基本完成,截至2022年12月31日止年度沒有確認此類收益。撇除拆遷收益,集團於2021年度錄得歸屬於公司權益持有人的綜合淨虧損為人民幣4920萬元。
經評估目前所得資料後,集團很有可能錄得2022年度歸屬於公司權益持有人的綜合淨利潤為人民幣7000萬元至人民幣9000萬元間;相比在計入拆遷收益前,2021年度歸屬於公司權益持有人的綜合淨虧損為人民幣4920萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.